Beta-Blocker Therapy and Survival After Hip Fracture Surgery Beta-Blocker Therapy and Survival After Hip Fracture Surgery
This study found that ongoing beta-blocker therapy was associated with a significant reduction in the risk of mortality within the first year after hip fracture surgery.Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 19, 2021 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Beta-Blockers May Reduce Mortality After Hip Fracture Surgery Beta-Blockers May Reduce Mortality After Hip Fracture Surgery
Data from a large Swedish Registry suggest that use of beta-blockers before and after surgery was associated with a 42% reduction of risk in the first postoperative year.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 4, 2021 Category: Consumer Health News Tags: Orthopaedics News Source Type: news

Association Between Premorbid Beta-Blocker Exposure and Sepsis Outcomes-The Beta-Blockers in European and Australian/American Septic Patients (BEAST) Study
Conclusions: This study suggests that β-blocker exposure pr ior to sepsis, especially to noncardioselective β blockers, may be associated with better outcome. The findings suggest prospective evaluation of β-blocker use in the management of sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 8, 2021 Category: Consumer Health News Source Type: news

Common blood pressure pills taken by millions of Brits may raise the risk of psoriasis, study warns
A review of 21 studies by Korean researchers found common drugs ACE inhibitors, beta blockers, calcium channel blockers (CCBs) and thiazide diuretics, increased the risk of psoriasis. (Source: the Mail online | Health)
Source: the Mail online | Health - October 6, 2021 Category: Consumer Health News Source Type: news

Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients
Might nonselective beta-blockers such as carvedilol, nadolol, and propranolol decrease the risk of hepatocellular carcinoma among patients with cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 6, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Beta-Blocker Reduces Lung Inflammation in Critical COVID-19 Beta-Blocker Reduces Lung Inflammation in Critical COVID-19
In a pilot trial, intravenous metoprolol given to patients with acute respiratory distress syndrome brought on by COVID-19 was safe, reduced lung inflammation, and improved oxygenation.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 2, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Antihypertensives Linked to Reduced Mortality in Colorectal Cancer
Reductions in mortality seen in association with ACE inhibitors, beta - blockers, thiazide diuretics (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 1, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news

Oral Contraceptives, Sans Beta Blockade, Raise SCD Risk in LQTS Oral Contraceptives, Sans Beta Blockade, Raise SCD Risk in LQTS
All women with congenital LQTS on progestin-only oral contraceptives should also be taking maximally tolerated beta blockers, say researchers who are studying the same issue in drug-induced LQTS.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 2, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Non - Antimicrobial Drugs Tied to Drug - Resistant Bacterial Infection
Proton pump inhibitors, beta - blockers, antimetabolites linked to infection with antibiotic - resistant bacteria (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 19, 2021 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Gastroenterology, Infections, Internal Medicine, Oncology, Pharmacy, Conference News, Source Type: news

Beta-Blocker Heart Meds Might Lower Arthritis Risk
TUESDAY, May 18, 2021 -- Commonly used beta blocker heart medicine may also reduce the risk of knee and hip osteoarthritis and pain, a new study suggests. " Osteoarthritis is the most common form of arthritis and affects 15% of the general... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2021 Category: General Medicine Source Type: news

Beta-Blocker Heart Meds Might Lower Arthritis Risk
Title: Beta-Blocker Heart Meds Might Lower Arthritis RiskCategory: Health NewsCreated: 5/18/2021 12:00:00 AMLast Editorial Review: 5/18/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - May 18, 2021 Category: Rheumatology Source Type: news

Beta-Blockers May Up Heart Risk for HIV Patients With Hypertension Beta-Blockers May Up Heart Risk for HIV Patients With Hypertension
The use of beta-blockers as a blood pressure treatment could increase the risk of heart disease for HIV patients, according to an analysis of data from the US Veterans Health Administration.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 21, 2021 Category: Intensive Care Tags: Cardiology News Source Type: news

Some Blood Pressure Meds Raise Heart Risks in People With HIV
TUESDAY, April 6, 2021 -- Beta-blocker blood pressure medications may increase the risk of heart problems in people with HIV, new research suggests. For the study, the researchers reviewed the medical records of more than 8,000 U.S. veterans with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 6, 2021 Category: General Medicine Source Type: news

Beta blockers could increase complications for HIV patients
The American Heart Association published findings Monday indicating HIV patients may have a higher risk of complications while on beta blockers prescribed to treat heart problems. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 5, 2021 Category: Consumer Health News Source Type: news

Certain high blood pressure medications may alter heart risk in people with HIV
(American Heart Association) Some blood pressure medications altered the likelihood of subsequent heart disease, stroke or heart failure in a study of veterans who have HIV (human immunodeficiency virus).Patients with HIV prescribed beta-blockers were more likely to develop cardiovascular disease compared to patients taking other blood pressure medications, even if their blood pressure was well controlled. All other classes of hypertensive medications showed no differences regarding cardiovascular risk outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2021 Category: International Medicine & Public Health Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What You Don't Know About Beta-Blockers and Hemodialysis What You Don't Know About Beta-Blockers and Hemodialysis
A new look at the literature turned up a finding that surprised this nephrologist.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 18, 2021 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

Beta Blockers Won ’ t Cause Depression, But Might Impair Sleep: Study
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - March 16, 2021 Category: Psychiatry Tags: Cardiology, Neurology, Psychiatry, News, Source Type: news

Beta Blockers Won't Cause Depression, But Might Impair Sleep: Study
TUESDAY, March 16, 2021 -- Millions of people take a beta blocker regularly, and a new study brings good news: The medications will not raise the risk of depression. Beta blockers are used to treat conditions such as heart failure, chest pains,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 16, 2021 Category: General Medicine Source Type: news

Beta Blockers Won't Cause Depression, But Might Impair Sleep: Study
Title: Beta Blockers Won't Cause Depression, But Might Impair Sleep: StudyCategory: Health NewsCreated: 3/16/2021 12:00:00 AMLast Editorial Review: 3/16/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 16, 2021 Category: Cardiology Source Type: news

Beta blockers not associated with risk of depression
(Charit é - Universit ä tsmedizin Berlin) Drugs such as beta-adrenergic antagonists (beta blockers) have been linked to a range of adverse effects, including depression. But how reliable are these data, and which psychiatric side effects might indeed be caused by these drugs? These questions have been addressed by a team of researchers from Charit é - Universit ä tsmedizin Berlin, whose comprehensive meta-analysis has been published inHypertension*. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2021 Category: International Medicine & Public Health Source Type: news

Certain Antihypertensives Tied to Benefit After Aortic Dissection Certain Antihypertensives Tied to Benefit After Aortic Dissection
In a population-based cohort study, use of either beta blockers, ACE inhibitors, or ARBS was associated with benefits vs other such agents in the long-term treatment of patients with aortic dissection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 10, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news

Is lactate lower in septic patients who are prescribed beta blockers? Retrospective cohort study of an intensive care population, Emergency Medicine Australasia 33(1): 82-87
Conclusions: In our cohort pre‐existing beta blocker treatment was associated with lower serum lactate measurements in patients presenting with sepsis. Pre‐existing beta blocker treatment may reduce serum lactate at presentatio n in patients with sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 3, 2021 Category: Consumer Health News Source Type: news

Beta-Blocker May Improve Melanoma Treatment Response Beta-Blocker May Improve Melanoma Treatment Response
Response rates were high without dose-limiting toxicities in a small phase 1 study that evaluated the addition of propranolol to pembrolizumab in treatment-naive patients with metastatic melanoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 10, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer treatment could be replicated for COVID-19
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists. University of South Australia cancer researcher, Dr Nirmal Robinson, working with a team in Naples, has found evidence in animal models that the beta-blocker Propranolol helps suppress the spread of cancer in the lung which has an inflammatory profile very similar to COVID-19. (Source: World Pharma News)
Source: World Pharma News - November 3, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Cancer treatment could be replicated for COVID-19
(University of South Australia) Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2020 Category: Cancer & Oncology Source Type: news

Consumer Health: Beta blockers and weight gain
Beta blockers are medications that reduce your blood pressure. They cause your heart to beat more slowly and with less force, which lowers blood pressure. Beta blockers also open up your veins and arteries to improve blood flow. Beta blockers are used to prevent, treat or improve symptoms in people who have irregular heart rhythm, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 29, 2020 Category: Databases & Libraries Source Type: news

Breakthroughs in COPD From ERS 2020 Breakthroughs in COPD From ERS 2020
Highlights in COPD from the ERS 2020 virtual congress include therapy escalation and de-escalation, compliance with GOLD guidelines, and a potential reason for the beneficial effect of beta-blockers.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news

Breast cancer medication risk
(Flinders University) New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients. Beta-blockers, commonly used to manage cardiovascular disease, were negatively associated with survival outcomes in patients with HER2 (Human Epidermal Growth Factor Receptor 2) positive advanced breast cancer, according to a new paper in the Frontiers In Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 29, 2020 Category: Cancer & Oncology Source Type: news

Review Finds Evidence for Beta-Blockers for Some Rosacea Symptoms Review Finds Evidence for Beta-Blockers for Some Rosacea Symptoms
The systematic review included a case control study of 53,927 patients and an equal number of controls that evaluated beta-blockers in general.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 28, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Sep 25 2020 This Week in Cardiology Sep 25 2020 This Week in Cardiology
COVID sport participation guidelines, beta-blockers after MI, and low-dose DOAC therapy in AF are the topics covered by John Mandrola, MD, in this week ’ s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2020 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Study Questions Routine Long-term Beta-Blocker Post MI Study Questions Routine Long-term Beta-Blocker Post MI
Long-term beta-blocker therapy prescribed after an acute MI might be obsolete in the modern reperfusion era, according to an analysis of Danish registry data.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

DAPA-CKD: SGLT2 Inhibitors'The Beta-Blockers for the Kidneys'DAPA-CKD: SGLT2 Inhibitors'The Beta-Blockers for the Kidneys '
Nephrologists Jennie Lin and Leslie Gewin discuss the effects of dapagliflozin in patients with CKD. How do the DAPA-CKD findings fit with the CREDENCE data on SGLT2 inhibitors?Medscape Nephrology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 4, 2020 Category: Intensive Care Tags: Nephrology Commentary Source Type: news

RATE-AF Trial Boosts Digoxin for Rate Control in Permanent AF RATE-AF Trial Boosts Digoxin for Rate Control in Permanent AF
Study results show equally good rate control with digoxin as with a beta-blocker, but with far fewer adverse events.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 31, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Nine Antihypertensive Drugs Associated With Reduced Risk for Depression Nine Antihypertensive Drugs Associated With Reduced Risk for Depression
A 2005-2015 study found reduced risk for depression in angiotensin agents (ACE inhibitors or angiotensin II receptor blockers), calcium antagonists, beta-blockers, and diuretics.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 26, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Antihypertensive Agents Not Tied to Higher Risk for Depression
MONDAY, Aug. 24, 2020 -- Nine individual antihypertensive agents from the classes of angiotensin agents, calcium antagonists, andβ-blockers are associated with reduced rates of depression, according to a study published online Aug. 24 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 24, 2020 Category: Pharmaceuticals Source Type: news

COX2 Inhibitor and Beta Blocker Combo to Reduce CRC Metastasis? COX2 Inhibitor and Beta Blocker Combo to Reduce CRC Metastasis?
Used perioperatively, the combination significantly improved biomarkers of malignancy and resulted in a lower recurrence rate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Medications May Drive Postmenopausal Weight Gain Medications May Drive Postmenopausal Weight Gain
Use of weight-promoting medications such as antidepressants, beta-blockers, insulin, and glucocorticosteroids may contribute to postmenopausal abdominal weight gain, data from the Women's Health Initiative indicate.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 24, 2020 Category: Psychiatry Tags: Diabetes & Endocrinology News Source Type: news

Prior Beta Blockers Predict Extra HF Burden in Women With ACS Prior Beta Blockers Predict Extra HF Burden in Women With ACS
Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 15, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Medication Use Linked to Weight Gain in Postmenopausal Women
Use of antidepressants, beta - blockers, insulin linked to increase in BMI, waist circumference (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 15, 2020 Category: Psychiatry Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Pharmacy, Psychiatry, Journal, Source Type: news

Medication Use Linked to Weight Gain in Postmenopausal Women
WEDNESDAY, July 15, 2020 -- For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years, according to a study published online July 15 in Menopause. Fatima Cody Stanford, M.D., M.P.H., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 15, 2020 Category: Pharmaceuticals Source Type: news

How much postmenopause weight gain can be blamed on weight-promoting medications?
(The North American Menopause Society (NAMS)) Abdominal weight gain, which is common during the postmenopause period, is associated with an array of health problems, including diabetes and heart disease. A new study suggests that the use of antidepressants, beta-blockers, and insulin during the menopause transition is partially to blame for such unhealthy weight gain. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2020 Category: International Medicine & Public Health Source Type: news

Beta Blocker Heart Meds Pose Special Risks
Title: Beta Blocker Heart Meds Pose Special RisksCategory: Health NewsCreated: 7/13/2020 12:00:00 AMLast Editorial Review: 7/14/2020 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - July 14, 2020 Category: Cardiology Source Type: news

Beta blockers may increase heart failure risk in women, study finds
Women who take beta blockers for high blood pressure are at nearly 5 percent higher risk for heart failure than men, even if they have no history of heart disease, according to a study published Monday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 13, 2020 Category: Consumer Health News Source Type: news

Beta Blocker Heart Meds Might Pose Special Risks for Women
MONDAY, July 13, 2020 -- Millions of Americans are prescribed blood pressure medicines called beta blockers, especially after a heart attack. But a new Italian study finds that these go-to drugs might not work as well for women as they do for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 13, 2020 Category: General Medicine Source Type: news

Risk for Heart Failure Increased for Women Taking β-Blockers
MONDAY, July 13, 2020 -- Women takingβ-blockers for hypertension have an increased risk for developing heart failure when they present to the hospital with acute coronary syndrome, according to a study published online July 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2020 Category: Pharmaceuticals Source Type: news

What if we could design powerful drugs without unwanted side effects?
(Stanford School of Engineering) The paper describes how to minimize or eliminate side effects in drugs that target G protein-coupled receptors. GPCRs are proteins found in all human cells. LSD and other psychedelics are molecules that attach to GPCRs, as are about a third of prescription drugs, including antihistamines, beta blockers and opioids. 'Armed with our results, researchers can begin to imagine new and better ways to design drugs that retain their effectiveness while posing fewer dangers.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2020 Category: International Medicine & Public Health Source Type: news

Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality after Sepsis:
Antagonists of the renin-angiotensin-aldosterone system (RAAS), including ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers), may prevent organ failure. We, therefore, investigated whether specific RAAS inhibitors are associated with reduced mortality in patients with sepsis.We conducted a population-based retrospective cohort study using multivariable propensity score-based regression to control for differences among patients using different RAAS inhibitors. A multivariable-adjusted Cox proportional-hazards regression model was used to determine the association between RAAS inhibi...
Source: Current Awareness Service for Health (CASH) - May 6, 2020 Category: Consumer Health News Source Type: news

Combining antidepressants with beta-blockers: evidence of a clinically significant CYP2D6 drug interaction - Shin J, Hills NK, Finley PR.
BACKGROUND: Beta-blockers and antidepressants are two of the most commonly prescribed drug classes in the United States. Several antidepressants are potent inhibitors of cytochrome P450 2D6 liver enzymes (CYP2D6) and can increase the plasma concentrations ... (Source: SafetyLit)
Source: SafetyLit - May 2, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Landiolol Effective for Sepsis-Related Tachyarrhythmias Landiolol Effective for Sepsis-Related Tachyarrhythmias
The ultra-short-acting beta blocker landiolol safely and effectively treated sepsis-related tachyarrhythmias in its first open-label randomized controlled trial, held in Japan.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 14, 2020 Category: Intensive Care Tags: Critical Care News Source Type: news